ANTIEMETIC ACTIVITY OF HIGH-DOSE METOCLOPRAMIDE COMBINED WITH METHYLPREDNISOLONE VERSUS METOCLOPRAMIDE ALONE IN DACARBAZINE-TREATED CANCER-PATIENTS - A RANDOMIZED DOUBLE-BLIND-STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH

被引：8

作者：

BASURTO, C

ROILA, F

TONATO, M

BALLATORI, E

BUZZI, F

CALABRESI, F

DELFAVERO, A

机构：

[1] CTR ONCOL G PORFIRI,LATINA,ITALY

[2] UNIV PERUGIA,DIPARTIMENTO SCI STAT,I-06100 PERUGIA,ITALY

[3] UNIV PERUGIA,IST CLIN MED 1,I-06100 PERUGIA,ITALY

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1989年 / 12卷 / 03期

关键词：

D O I：

10.1097/00000421-198906000-00011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：235 / 238

页数：4

共 9 条

[1] ANTIEMETIC PROPHYLAXIS WITH HIGH-DOSE METOCLOPRAMIDE OR LORAZEPAM IN VOMITING INDUCED BY CHEMOTHERAPY [J].

BOWCOCK, SJ ;

STOCKDALE, AD ;

BOLTON, JAR ;

KANG, AA ;

RETSAS, S .

BRITISH MEDICAL JOURNAL, 1984, 288 (6434) :1879-1879

[2]

DOODS LJ, 1985, J CLIN HOSP PHARM, V10, P143

[3] THE MANAGEMENT OF CHEMOTHERAPY - INDUCED NAUSEA AND VOMITING [J].

GRALLA, RJ ;

TYSON, LB ;

KRIS, MG ;

CLARK, RA .

MEDICAL CLINICS OF NORTH AMERICA, 1987, 71 (02) :289-301

[4]

MITCHELL EP, 1982, SEMIN ONCOL, V9, P52

[5]

PLEZIA PM, 1985, CLINICS ONCOL, V4, P357

[6]

PRUITT BT, 1985, TEX MED, V81, P44

[7]

ROILA F, 1985, CANCER TREAT REP, V69, P1353

[8] ANTIEMETIC ACTIVITY OF HIGH-DOSES OF METOCLOPRAMIDE COMBINED WITH METHYLPREDNISOLONE VERSUS METOCLOPRAMIDE ALONE IN CISPLATIN-TREATED CANCER-PATIENTS - A RANDOMIZED DOUBLE-BLIND TRIAL OF THE ITALIAN-ONCOLOGY-GROUP-FOR-CLINICAL-RESEARCH [J].

ROILA, F ;

TONATO, M ;

BASURTO, C ;

BELLA, M ;

PASSALACQUA, R ;

MORSIA, D ;

DICOSTANZO, F ;

DONATI, D ;

BALLATORI, E ;

TOGNONI, G ;

FRANZOSI, MG ;

DELFAVERO, A .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) :141-149

[9]

TYSON LB, 1982, CANCER TREAT REP, V66, P2108

← 1 →